ATE312113T1 - Hemmung der denaturierung von nukleinsäure- duplexen - Google Patents

Hemmung der denaturierung von nukleinsäure- duplexen

Info

Publication number
ATE312113T1
ATE312113T1 AT01936687T AT01936687T ATE312113T1 AT E312113 T1 ATE312113 T1 AT E312113T1 AT 01936687 T AT01936687 T AT 01936687T AT 01936687 T AT01936687 T AT 01936687T AT E312113 T1 ATE312113 T1 AT E312113T1
Authority
AT
Austria
Prior art keywords
nucleic acid
inhibiting
denaturation
acid duplexes
proteins
Prior art date
Application number
AT01936687T
Other languages
English (en)
Inventor
Neil Butt
Matthew Baker
Navin Pathirana
Original Assignee
Whatman Internat Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whatman Internat Ltd filed Critical Whatman Internat Ltd
Application granted granted Critical
Publication of ATE312113T1 publication Critical patent/ATE312113T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01936687T 2000-06-12 2001-06-11 Hemmung der denaturierung von nukleinsäure- duplexen ATE312113T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0014324A GB2363381B (en) 2000-06-12 2000-06-12 Solution
PCT/GB2001/002564 WO2001096351A1 (en) 2000-06-12 2001-06-11 Inhibiting denaturation of nucleic acid duplexes

Publications (1)

Publication Number Publication Date
ATE312113T1 true ATE312113T1 (de) 2005-12-15

Family

ID=9893476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01936687T ATE312113T1 (de) 2000-06-12 2001-06-11 Hemmung der denaturierung von nukleinsäure- duplexen

Country Status (7)

Country Link
US (2) US7244561B2 (de)
EP (1) EP1290003B1 (de)
AT (1) ATE312113T1 (de)
AU (1) AU2001262554A1 (de)
DE (1) DE60115637T2 (de)
GB (1) GB2363381B (de)
WO (1) WO2001096351A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0129662D0 (en) * 2001-12-11 2002-01-30 Whatman Internat Ltd Stabilisation of double-stranded nucleic acids
US7794932B2 (en) 2004-04-16 2010-09-14 Piotr Chomczynski Reagents and methods for isolation of purified RNA
EP3115039B1 (de) * 2015-07-09 2021-12-15 beniag GmbH Verfahren zum herstellen einer fusionsmischung zur übertragung eines geladenen moleküls in und/oder durch eine lipidmembran

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668618A (en) * 1981-09-14 1987-05-26 Thornthwaite Jerry T Nuclear isolation medium and procedure for separating cell nuclei
EP0310913A3 (de) * 1987-09-30 1990-04-25 Biotechnica Diagnostics Inc Verfahren zur Isolierung von DNS
US5756126A (en) * 1991-05-29 1998-05-26 Flinders Technologies Pty. Ltd. Dry solid medium for storage and analysis of genetic material
CA2031659A1 (en) * 1990-01-26 1991-07-27 John B. Findlay Water-insoluble reagent, nucleic acid probe, test kit and diagnostic and purification methods
US5866429A (en) * 1991-04-03 1999-02-02 Bloch; Will Precision and accuracy of anion-exchange separation of nucleic acids
WO1992018649A1 (en) * 1991-04-12 1992-10-29 Microprobe Corporation Compositions and methods for improved extraction and hybridization of nucleic acid
AU7375794A (en) * 1993-07-28 1995-02-28 Akzo Nobel N.V. Process for isolating nucleic acid from gram positive microorganisms
EP0814156B1 (de) * 1996-06-18 2003-03-05 The Institute Of Physical & Chemical Research Verfahren zur Reinigung von DNS
US5922536A (en) * 1996-10-18 1999-07-13 Nivens; David E. Method for nucleic acid isolation using supercritical fluids
US6844158B1 (en) * 1997-12-22 2005-01-18 Hitachi Chemical Co., Ltd. Direct RT-PCR on oligonucleotide-immobilized PCR microplates
EP1119576B1 (de) 1998-10-09 2003-06-11 Whatman Bioscience Limited Verfahren zur isolierung von nukleinsäure und vorrichtung hierfür
EP1337670A4 (de) * 2000-08-16 2004-07-14 Whatman Inc Transfusionsmedizinfiltriermittel zur abreicherung von leukozyten als quelle für genetisches material für genotypisierungsstudien

Also Published As

Publication number Publication date
GB0014324D0 (en) 2000-08-02
US7501500B2 (en) 2009-03-10
DE60115637D1 (de) 2006-01-12
US20030157520A1 (en) 2003-08-21
GB2363381A (en) 2001-12-19
EP1290003A1 (de) 2003-03-12
US20070281316A1 (en) 2007-12-06
AU2001262554A1 (en) 2001-12-24
DE60115637T2 (de) 2006-08-24
WO2001096351A1 (en) 2001-12-20
US7244561B2 (en) 2007-07-17
GB2363381B (en) 2004-11-24
EP1290003B1 (de) 2005-12-07

Similar Documents

Publication Publication Date Title
DE69634912D1 (de) Intrazellulare domäne des her-2/neu proteins, für die prevention oder behandlung von bösartigen tumoren
BR9407047A (pt) Processo para separaçao de uma proteina de uma soluçao aquosa de proteinas
BRPI0213786B8 (pt) peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
BR9811509A (pt) Compostos de organo-silano estabilizados em água e métodos para uso dos mesmos.
ATE374815T1 (de) Methode zur erhöhung der konzentration von nucleinsäuremolekülen
TR28856A (tr) Amino asit polimerlerinin hazirlanmasi icin islem
ATE252830T1 (de) Neue psoralene zur inaktivierung von pathogenen
ATE352639T1 (de) Antisense modulation der expression von integrin alpha 4
WO2004003172A3 (en) Esm-1 gene differentially expressed in angiogenesis, antagonists thereof, and methods of using the same
DE69906568D1 (de) Behandlung von hämorrhagischem virusfieber mit protein c
ATE312113T1 (de) Hemmung der denaturierung von nukleinsäure- duplexen
MX9702776A (es) Proteinas de proteasa de pulgas, moleculas de acido nucleico, y usos de las mismas.
Poonsin et al. Major trypsin like‐serine proteinases from albacore tuna (Thunnus alalunga) spleen: Biochemical characterization and the effect of extraction media
DE69732857D1 (de) Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen
NO972065D0 (no) Lagringsstabil vannopplösning for infusjon inneholdende en trombininhibitor
ATE281165T1 (de) Verwendung von pramipexol zur behandlung von restless-legs-syndrom
BR9910787A (pt) Métodos e composições úteis para modulação deangiogênese usando tirosina cinase src
NO991419D0 (no) Farmas°ytiske sammensetninger omfattende S-alkylisotiouroniumderivater
DK0512087T3 (da) Fremgangsmåde til reaktivering af denaturerede proteiner
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
ES2172248T3 (es) Un procedimiento para preparar un kappa-caseino glicopeptido o un derivado del mismo.
DE60218528D1 (de) Verfahren zur reinigung von cumenhydroperoxid spaltprodukten
ATE245438T1 (de) Verwendung von oligomerem matrixprotein aus knorpel zur behandlung von rheumatoider arthritis
WO1999055885A3 (en) Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties